A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

The Houston-based Empower Pharmacy is seeking to dismiss a lawsuit that targets its ability to sell popular diabetes and ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

GLP-1 drugs such as Wegovy, Ozempic and Mounjaro are transforming weight loss and reshaping the food industry - driving ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.

ABC News' Dr. Tara Narula explains a new study indicating that stopping GLP 1 weight loss medications too soon could make it harder to lose weight.

While these new drugs are curbing enthusiasm for eating, they are also having a notable effect on food purchases.

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

McDonald’s stock was heading for its longest losing streak in 12 years after Redburn Atlantic recommended investors sell due ...